CD20 Positive B Cell Non-Hodgkin's Lymphoma (DBCOND0092566)

Identifiers

Synonyms

CD20-positive B-cell Non-Hodgkin's Lymphoma / CD20 Positive B Cell NHL / CD20-positive B Cell Non-Hodgkin Lymphoma / CD20-positive B-cell Non-Hodgkin Lymphoma

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05805943	Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma	No drug interventions	treatment	1 / 2	recruiting
NCT03980379	Pharmacokinetics, Efficacy and Safety of the 304 Injection	Rituximab	treatment	1	unknown_status
NCT03332121	B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma	No drug interventions	treatment	1	completed
NCT04103905	A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas	No drug interventions	treatment	1	completed
NCT01569750	A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma	No drug interventions	treatment	1	completed
NCT05395533	A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.	No drug interventions	treatment	1	recruiting